Pratap Devarapalli, Ph.D., wissenschaftlicher Mitarbeiter an der TC Bernie School of Law der University of Queensland, Australien, wird sein kürzlich erschienenes Buch vorstellen: Bioinked Boundaries – Patenting 3D Bioprinted Tissues, Organs and Bioinks: An US, European and Australian Patent Law Perspective.
In seinem Vortrag wird Pratap Devarapalli insbesondere auf die Perspektive der EU eingehen.
Moderation: Prof. Dr. Hanns Ullrich
Veranstaltungssprache ist Englisch.
Abstract:
3D bioprinting, a technology that allows for the creation of human tissues and, potentially, entire organs, stands at the cutting edge of innovation in the life sciences. Three-dimensional bioprinting involves the use of bioinks, composed of living stem cells, to print complex organic structures layer by layer, mimicking the architecture of biological tissues. The implications for industrial applications are varied and the potential financial impact and human benefit are staggering. For example, in medicine bioprinted tissues could revolutionise drug testing, eliminate the need for animal models, and aim to offer solutions to the global organ shortage. Bioprinted tissues, much like genetically modified organisms, involve both natural materials and human intervention. However, as with many biotechnological advancements, the legal questions that surround bioprinting are equally complex. Can a tissue printed from living cells be considered an invention? How much modification is required to transform a biological material into something that qualifies as patentable subject matter? And how should courts and patent offices balance the need to protect innovation with the need to ensure public access to important medical technologies?
